NMN raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-11-03. Anything still debated is marked as such rather than presented as settled.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
NMN is present in small amounts in various foods, including certain vegetables, fruits, and milk, though dietary quantities are generally low. Laboratory research often uses synthetic or enzymatically produced NMN. The compound has drawn interest because NAD+ levels decline with age in some tissues and because restoring NAD+ may affect metabolism in animal models. Whether oral NMN produces meaningful NAD+ increases in humans and whether such changes translate into health benefits are not fully established.
Quality control for NMN materials usually covers identity, assay purity, residual solvents, heavy metals, microbial limits, and moisture content. Certificates of analysis from suppliers may report high-performance liquid chromatography purity, mass spectrometry identity, and elemental impurity testing. Regulatory treatment differs by country: NMN is not an approved drug, and its status as a dietary supplement ingredient or novel food has been debated. Some authorities have restricted sales pending safety and regulatory review, while others allow it under specific categories. Buyers should verify documentation rather than rely on label claims.
Quantifying NMN requires methods that separate it from structurally similar compounds such as nicotinamide, nicotinamide riboside, and NAD+. Common approaches include high-performance liquid chromatography coupled with ultraviolet detection, liquid chromatography with tandem mass spectrometry, capillary electrophoresis, and nuclear magnetic resonance for identity confirmation. Because NMN is polar and often present at low concentrations in biological samples, sample preparation can involve protein precipitation, solid-phase extraction, or derivatization. Isotope-labeled internal standards help correct for matrix effects and recovery losses. Reported concentrations depend heavily on the matrix, extraction protocol, and analytical platform.
Stability of NMN depends on physical form, temperature, moisture, light, and pH. The solid compound is generally more stable than aqueous solutions, which can degrade over time, especially when warm or exposed to extreme pH. Recommended laboratory storage is typically desiccated at −20 °C or below, protected from light, with containers sealed to limit moisture uptake. In solution, degradation products may include nicotinamide and related ribosides, and the rate varies with buffer composition and concentration. Analytical laboratories often prepare fresh solutions and validate stability for each method.
| Property | Value | Notes |
|---|---|---|
| Chemical name | Nicotinamide mononucleotide | Abbreviated NMN |
| Molecular formula | C11H15N2O8P | Neutral form |
| Molar mass | 334.22 g/mol | Approximate value |
| Appearance | White to off-white powder | Typical solid form |
| Solubility | Water-soluble | May absorb moisture |
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
Commercial NMN is produced through enzymatic or chemical routes, and the resulting material can vary in purity, counterion, and residual solvent content. Buyers typically rely on certificates of analysis, but independent verification through third-party laboratories provides stronger assurance. Regulatory treatment differs by country; in the United States, NMN has been subject to shifting guidance about its status as a dietary supplement, while other markets permit sales under local rules. No universal pharmacopeial monograph exists for NMN, so specifications often come from suppliers, research protocols, or regional requirements.
Solid NMN is generally handled as a moisture-sensitive compound. Dry material stored desiccated at low temperature, protected from light, tends to remain stable for extended periods. Aqueous solutions are less stable and can undergo hydrolysis, especially at elevated temperature or alkaline pH. The anomeric form also matters: beta-NMN is the naturally occurring form, while alpha-NMN can appear as a synthetic impurity. Purity and storage conditions therefore influence both analytical results and experimental reproducibility.
Penicillins (P, PCN or PEN) are a group of β-lactam antibiotics originally obtained from Penicillium moulds, principally P. chrysogenum and P. rubens. Eight species of Penicillium, in the section Chrysogena, produce penicillins. Most penicillins in clinical use are synthesised by P. chrysogenum using deep tank fermentation and then purified. A number of natural penicillins have been discovered, but only two purified compounds are in clinical use: penicillin G (intramuscular or intravenous use) and penicillin V (given by mouth). Penicillins were among the first medications to be effective against many bacterial infections caused by staphylococci and streptococci. They are still widely used today for various bacterial infections, though many types of bacteria have developed resistance following extensive use. In the United States, 10% of the population claims penicillin allergies, but because the frequency of positive skin test results decreases by 10% with each year of avoidance, 90% of these patients can eventually tolerate penicillin. Additionally, those with penicillin allergies can usually tolerate cephalosporins (another group of β-lactam) because the immunoglobulin E (IgE) cross-reactivity is only 3%. Penicillin was discovered in 1928 by the Scottish physician Alexander Fleming as a crude extract of P. rubens. Fleming's student Cecil George Paine was the first to successfully use penicillin to treat eye infection (neonatal conjunctivitis) in 1930.
In June 2013, two biosimilar versions (Inflectra and Remsima) were submitted for approval in the European Union, by Hospira and Celltrion Healthcare respectively. Both had a positive opinion from European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for sale in the European Union (EU). Celltrion obtained marketing authorization approval (MAA) from 27 EU countries and 3 EEA (European Economic Area) countries by September 2013. Inflectra was approved for use in the European Union in September 2013, and Remsima was approved for use in the European Union in October 2013. In Japan, Celltrion received marketing authorization for Remsima from Japan's Ministry of Health, Labour and Welfare (MHLW) in July 2014. In India, Epirus Biopharmaceuticals obtained approval to produce biosimilar infliximab under the brand name "Infimab" (trail name BOW015). The US Food and Drug Administration (FDA) approved Celltrion/Hospira/Pfizer's Inflectra (infliximab-dyyb) in April 2016. The FDA approved Samsung Bioepis Co., Ltd.'s Renflexis (infliximab-abda) in April 2017. Biogen released another biosimilar, Flixabi, which was approved in Germany, the UK, and the Netherlands. Flixabi was approved for use in the European Union in May 2016. In December 2017, Ixifi (infliximab-qbtx) was approved in the United States. Zessly was approved for use in the European Union in May 2018. In December 2019, Avsola (infliximab-axxq) was approved in the United States. Avsola was approved for medical use in Canada in March 2020.
This means that substitution models can be viewed as implying a specific multinomial distribution for site pattern frequencies. If we consider a multiple sequence alignment of four DNA sequences there are 256 possible site patterns so there are 255 degrees of freedom for the site pattern frequencies. However, it is possible to specify the expected site pattern frequencies using five degrees of freedom if using the Jukes-Cantor model of DNA evolution, which is a simple substitution model that allows one to calculate the expected site pattern frequencies only the tree topology and the branch lengths (given four taxa an unrooted bifurcating tree has five branch lengths). Substitution models also make it possible to simulate sequence data using Monte Carlo methods. Simulated multiple sequence alignments can be used to assess the performance of phylogenetic methods and generate the null distribution for certain statistical tests in the fields of molecular evolution and molecular phylogenetics. Examples of these tests include tests of model fit and the "SOWH test" that can be used to examine tree topologies.
After the internationalization of the war, several among them stepped off the fence and entered the political contest. The French strategy of inducing the Viet Minh to attack well-defended bases in remote areas at the end of their logistical trails succeeded at the Battle of Nà Sản. French efforts were hampered by the limited usefulness of tanks in forest terrain, the lack of a strong air force, and reliance on soldiers from French colonies. The Viet Minh used novel and efficient tactics, including direct artillery fire, convoy ambushes, and anti-aircraft weaponry to impede land and air resupplies, while recruiting a sizable regular army facilitated by large popular support. They used guerrilla warfare doctrine and instruction from China, and used war materiel provided by the Soviet Union. This combination proved fatal for the French bases, culminating in a decisive French defeat at the Battle of Dien Bien Phu. An estimated 400,000 to 842,707 soldiers died during the war as well as between 125,000 and 400,000 civilians. Both sides committed war crimes, including killings of civilians (such as the Mỹ Trạch massacre by French troops), rape and torture. The State of Vietnam gained full independence legally in June 1954, although the transfer of power was not yet complete. Despite gaining a great military advantage and controlling most of the country's territory, the Viet Minh had to accept a separation at the 17th parallel due to diplomatic pressure from the Chinese.
Andrej Janež is a Slovenian diabetologist and diabetes researcher. Janež is the Head of Department of Endocrinology, Diabetes and Metabolic Disease at University Medical Centre Ljubljana, Assistant Professor for Internal Medicine at the Medical University Ljubljana, Chairman of the Advances in Diabetes and Insulin Therapy conference, member of the advisory board for peroral antidiabetic therapy in Servier Pharma, member for Slovenia in the Diabetes Education Study Group at European Association for the Study of Diabetes, and member of the European advisory board for continuous glucose monitoring system in development for Lifescan. Janež authored numerous articles on diabetology and indexed by Science Citation Index, co-edited a clinical manual on continuous subcutaneous insulin infusion therapy, or insulin pump treatment. The latter is also the best known area of Janež's scientific work, as he introduced insulin pump treatment to India, Turkey, China, Slovenia, and several other countries, where he also led the effort of educating teams of diabetologists required for a continuous application of the technique.
Sources: en.wikipedia.org
== Decaffito == As of 2009, progress toward growing coffee beans that do not contain caffeine was still continuing. The term "Decaffito" has been coined to describe this type of coffee, and trademarked in Brazil. The prospect for Decaffito-type coffees was shown by the discovery of the naturally caffeine-free Coffea charrieriana variety, reported in 2004. It has a deficient caffeine synthase gene, leading it to accumulate theobromine instead of converting it to caffeine. Either this trait could be bred into other coffee plants by crossing them with C. charrieriana, or an equivalent effect could be achieved by knocking out the gene for caffeine synthase in normal coffee plants.
The library of oligonucleotides must be extremely diverse and not contain linear, incapable of providing a stable spatial arrangement, and double-stranded structures; due to these limitations, oligonucleotide libraries can cover the diversity of only ~106 sequences. This means that existing aptamers may not fully cover the diversity of target molecules or may not have optimal properties due to limitations of the underlying method. To yield the best possible aptamers one must maximize the effectiveness of the discovery process and the library itself. RNA and DNA secondary structure prediction by dynamic programming algorithms such as RNAfold (ViennaRNA) and by machine learning models such as SPOT-RNA, MXfold2 provides the opportunity to assess the ability of sequences in the primary library to fold into complex structures, allowing for the selection of only the most promising sequences from the entire pool. However, these algorithms are low-performance, making them poorly suited for this task. For this reason, algorithms like Ufold from the University of California and AliNA from Xelari Inc. have been developed, which demonstrate a significant increase in computational speed due to their faster architecture, and can be applied for preliminary in silico analysis of these libraries.
=== Marijuana === Moore supported legislation introduced and passed during the 2022 legislative session that created a ballot referendum to legalize recreational marijuana in Maryland, and another bill that would regulate marijuana possession should the referendum pass in November. During his 2022 gubernatorial campaign, Moore talked about implementing a recreational cannabis industry with a focus on equity "so that communities that have experienced the greatest disparities benefit the most." Question 4 passed with 67.2 percent of voters approving the measure on November 8, 2022. In January 2023, Moore signed an executive order releasing $46.5 million to start developing the framework for a recreational marijuana industry in the state, with a majority of the released funds going toward grants for minority-owned firms. In May 2023, he signed a bill regulating the state's recreational marijuana industry. In October 2022, Moore praised President Joe Biden's pardon of thousands of people convicted of marijuana possession under federal law, and said that he would "fight to expunge the records of those arrested for marijuana possession [as governor]". In June 2024, Moore signed an executive order pardoning about 100,000 people with low-level cannabis-related convictions in Maryland. In June 2025, he pardoned an additional 6,900 individuals convicted of simple cannabis possession. In May 2023, Moore allowed a bill that prohibits police from stopping a vehicle solely based on if they smell marijuana to become law without his signature.
=== Mammalian cells === The method of detection of a field in mammalian cells is under active investigation and might involve several mechanisms. For now, it is thought that redistribution of membrane-bound sensors dragged by Coulombic forces and electro-osmosis at the membrane would cause the cell to polarize, then migrate. Mathematical modeling suggests that a 6-10% change in sensor concentration across the cell is detectable. Experiments that repeatedly changed orientation of a field applied to several cell lines suggest that sensor polarization occurs on a relatively rapid timescale, perhaps several seconds, compared to the cell migration response, which is observed after 5–10 minutes. This allows cells to time-average changes in the direction of the electric field before migrating.
Sources: en.wikipedia.org
=== United States === The United States Code of Federal Regulations standard for blue cheese specifies a minimum milkfat content of 50 percent, and maximum moisture of 46 percent. Optional ingredients permitted include food coloring to neutralize the yellowish tint of the cheese, benzoyl peroxide bleach, and vegetable wax for coating the rind.
=== New books === Thomas Charles - Geiriadur Ysgrythyrol Theophilus Jones - History of the County of Brecknock, vol. 1 Titus Lewis - A Welsh — English Dictionary, Geiriadur Cymraeg a Saesneg Robert Southey - Madoc
spindle apparatus The cytoskeletal structure that forms during cell division in eukaryotic cells, consisting of a network of long, flexible microtubules extending from each pole of the parent cell and attaching to kinetochores at the centromeres of homologous chromosomes or sister chromatids near the cell equator. As the microtubules shorten, they pull the chromosomes apart, separating them into different daughter cells. Proper formation of this apparatus is critical in both mitosis and meiosis, where it is respectively referred to as the mitotic spindle and meiotic spindle.
His method of testing won the Intel International Science and Engineering Fair Gordon E. Moore Award in the spring of 2012. The Boeing Company has patented the use of carbon nanotubes for structural health monitoring of composites used in aircraft structures. This technology is hoped to greatly reduce the risk of an in-flight failure caused by structural degradation of aircraft. Zyvex Technologies has also built a 54' maritime vessel, the Piranha Unmanned Surface Vessel, as a technology demonstrator for what is possible using CNT technology. CNTs help improve the structural performance of the vessel, resulting in a lightweight 8,000 lb boat that can carry a payload of 15,000 lb over a range of 2,500 miles. IMEC is using carbon nanotubes for pellicles in semiconductor lithography. In tissue engineering, carbon nanotubes have been used as scaffolding for bone growth. Carbon nanotubes can serve as additives to various structural materials. For instance, nanotubes form a tiny portion of the material(s) in some (primarily carbon fiber) baseball bats, golf clubs, car parts, or damascus steel. IBM expected carbon nanotube transistors to be used on Integrated Circuits by 2020.
Alexander McLeish. For services to Charity. Martin Gerard McTague. Low Pay Commissioner and National Chair, UK Federation of Small Businesses. For services to Small Businesses. Thomas Anthony Meadows. Lead Operations Manager, Security Services Group, Defence Infrastructure Organisation. For services to Defence. Dr. Teame Mebrahtu. For services to Education, to Refugees and to the community in Bristol. Dr. Nicholas John Merriman. Chief Executive, The Horniman Museum and Gardens. For services to the Arts and to Heritage. Gillian Jayne Millane. Co-Founder, Love Grace. For services to Charitable Fundraising and Tackling Violence Against Women. Dr. Jane Patricia Monckton-Smith. Professor of Public Protection, University of Gloucestershire. For services to Criminal Justice. Keith Morgan. Coach, Crystal Palace Weightlifting Club. For services to Sport. Andrew David Murphy. Lately Chief Operating Officer, John Lewis Partnership. For services to the British Retail Industry. Professor James Michael Olu N'Dow, DL. Professor of Urological Surgery, University of Aberdeen. For services to Cancer and Urology, and to Voluntary Work. Professor Kimberley Anne-Isola Nekaris. Head, Nocturnal Primate Research Group, Oxford Brookes University. For services to Conservation. Kenneth Paul Newton. Governing Governor, HM Prison Birmingham. For Public Service. Robert Stewart Nicol. Lately Chief Executive, Inverness Chambers of Commerce. For services to the Economy of the Highlands of Scotland. Beryce Amy Nixon. Chief Executive Officer, Exceed Learning Partnership Trust. For services to Education.
Sources: en.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ biosynthesis. It occurs naturally in cells and is also produced commercially as a supplement ingredient.
No. NMN is a precursor that can be converted into NAD+, while NAD+ is a dinucleotide coenzyme involved in redox reactions and signaling.
Small amounts have been reported in foods such as edamame, avocado, broccoli, and milk. Dietary amounts are generally much lower than those used in research studies.
Liquid chromatography with tandem mass spectrometry is common because it can quantify low levels of NMN in complex samples. High-performance liquid chromatography with ultraviolet detection is used for simpler purity checks. Nuclear magnetic resonance can confirm identity and detect some impurities.